Periodic Reporting for period 1 - MEDIVAC (Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems)
Berichtszeitraum: 2017-06-01 bis 2017-10-31
OncoImmunity is currently developing a state-of-the-art software solution that addresses this problem– the Immune Profiler prediction engine (PE) which leverages advanced machine-learning algorithms and bioinformatics approaches to predict whether a potential neoantigen has the correct physiochemical features to be immunogenic. However, to fully enable the development of personalized vaccines this software need to be customized to specific vaccine delivery systems (VDS) as different vaccine platforms induce responses against different repertoires of neoantigen. The tailored software will be called MEDIVAC.